FIELD: medicine. SUBSTANCE: method involves intravenously administering polyosm at a dose of 200 ml daily once a day during 3 days. EFFECT: enhanced effectiveness of treatment; accelerated treatment course. 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING EDEMATOUS-HEMORRHAGIC FORMS OF DIABETIC RETINOPATHY | 2004 |
|
RU2265425C1 |
METHOD FOR TREATING OEDEMATOUS FORM OF DIABETIC MACULORETINOPAHTY | 2008 |
|
RU2367386C1 |
METHOD OF TREATING MACULAR OEDEMA ACCOMPANYING RETINOVASCULITIS | 2013 |
|
RU2562022C2 |
METHOD FOR MODELLING CEREBRAL ISCHEMIA DISEASE AGGRAVATED BY HEMISPHERE ASYMMETRY PHENOMENA | 1993 |
|
RU2083000C1 |
METHOD OF TREATING EARLY MANIFESTATIONS OF AGE-RELATED MACULAR RETINAL DEGENERATION | 2014 |
|
RU2549673C1 |
HEMORHEOLOGICAL AGENT | 1998 |
|
RU2138285C1 |
AGENT INHIBITING ANGIOGENESIS IN VISUAL ORGAN DISEASE | 2001 |
|
RU2177801C1 |
THERAPY OF RECURRENT ACHING BULLOUS KERATOPATHY FOLLOWING PHOTOTHERAPEUTIC GLAUCOMA EYE KERATECTOMY | 2006 |
|
RU2353341C2 |
RETINOPROTECTOR | 2009 |
|
RU2406487C1 |
METHOD OF TREATING DIABETIC MACULAR OEDEMA | 2010 |
|
RU2438637C1 |
Authors
Dates
2003-10-20—Published
2001-10-01—Filed